Soft tissue sarcoma (STS) are a broad group of rare tumors. Cornerstone of treatment is
surgery. Complementary radiotherapy is recommended in high-risk STS arising from …

Objectives We review our institution's experience in treating leiomyosarcomas involving the
inferior vena cava, and we offer guidance on the management. Methods A text-based search …

Purpose This nationwide retrospective study was conducted to evaluate the efficacy and
safety of combined gemcitabine and docetaxel (GD) as an off-label therapy for advanced …

Docetaxel-associated palmar-plantar erythrodysesthesia is rarely reported in literature,
particularly when used in the treatment of sarcomas. Here, we report a case of docetaxel …

Abstract A randomized Phase II/III trial was planned to commence in March 2014.
Perioperative chemotherapy with adriamycin plus ifosfamide is the current standard …

Background The prognosis of patients with metastatic or advanced sarcomas is poor and
there are few options for treatment. Several studies have shown that gemcitabine and …

Background Bone and soft tissue sarcomas (BSTS) are rare malignant tumors. Recently, the
combination of gemcitabine and docetaxel (GD) was shown to have activity as second-line …

Background: Prognosis and survival for patients with metastatic soft tissue sarcoma (STS)
are dismal. Standard first-line systemic chemotherapy is anthracycline-based. Gemcitabine …

Patients with advanced soft tissue sarcoma (aSTS) typically have a poor prognosis. Patients
progressing to doxorubicin-based regimen have limited therapeutic options. Monotherapy …

吉西他滨联合多西他赛治疗晚期软组织肉瘤11例 首页 期刊简介 1.期刊介绍 2.获奖情况 编委会
期刊在线 1.最新录用 2.优先发表 3.当期目录 4.过刊浏览 视频合辑 在线投稿 1.投稿须知 2.稿约 …